Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 16 MARCH 2022

Patient Support Programs

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

An obligation for marketing authorisation holders to apply to the TITCK and obtain permission for training and support programs for patients/healthcare professionals for...

TurkeyFood, Drugs, Healthcare, Life Sciences
Gün + Partners
Gün + Partners
Author LinkedIn connections

An obligation for marketing authorisation holders to apply to the TITCK and obtain permission for training and support programs for patients/healthcare professionals for the rational use of drugs was regulated via Circular numbered 2016/4 dated March 14 2016, published by the TITCK.

With the program, the marketing authorisation holder signs a contract with an organisation that has been licensed within the framework of the "Regulation on the Delivery of Home Care Services" to train patients or their relatives or healthcare professionals in the clinic/health institution about the product application, or to establish a call centre to obtain information about the product application by the patients' relatives.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Medical Malpractice In Health Tourism In Turkey: A Guide For Foreign Patients

Turkey has become a major destination for medical tourism, but when treatment goes wrong abroad, patients often don't know their legal rights. This guide examines the regulatory framework governing health tourism in Turkey, common causes of medical malpractice in cosmetic and dental procedures, and the practical steps foreign patients can take to pursue compensation claims under Turkish law.
TurkeyFood, Drugs, Healthcare, Life Sciences
Oran Partners Law Firm
Oran Partners Law Firm
Article

New Pricing Communiqué Following The New Pricing Decision For Medicinal Products For Human Use: Increase Of The Euro Conversion Rate To 65% Of The Previous Year’s Average And Details Of The Pricing Incentive For The First Equivalent/Generic Product

Turkey's pharmaceutical pricing system undergoes a major restructuring with the publication of the New Pricing Communiqué on August 29, 2026, implementing significant changes including increased Euro/TRY conversion rates, incentive mechanisms for first generic market entry, and the introduction of value-based pricing concepts. The new regulations establish detailed provisions for special product categories while leaving certain implementation details to future secondary legislation.
TurkeyFood, Drugs, Healthcare, Life Sciences
Gün + Partners
Gün + Partners
Article

Recent Developments In Healthcare Legislation – Issue 2026/2

Turkey's Medicines and Medical Devices Agency has introduced sweeping regulatory reforms across pharmaceuticals, medical devices, and cosmetics sectors. The amendments streamline biosimilar development by eliminating redundant testing requirements, establish new licensing frameworks for herbal products and aromatherapeutic oils, and impose stricter labeling standards for allergens in cosmetics. These changes fundamentally reshape compliance obligations for manufacturers, importers, and healthcare institutio
TurkeyFood, Drugs, Healthcare, Life Sciences
Paksoy
Paksoy
Article

Communiqué On Marks Or Numbers Identifying The Lot To Which Foods Belong Published

Turkey has introduced a new Food Codex Communiqué that fundamentally restructures how food lot identification markings must be determined and displayed on product labels. The regulation shifts responsibility for lot number determination directly to food producers, expands record-keeping obligations, and establishes new compliance requirements that all food business operators must meet by the end of 2026.
TurkeyFood, Drugs, Healthcare, Life Sciences
Moroglu Arseven
Moroglu Arseven
Article

Data Protection And Privacy Law In Türkiye Key Developments And Predictions - 2026

This comprehensive report examines the evolving landscape of personal data protection in Türkiye, analyzing regulatory developments, enforcement trends, and emerging compliance challenges through 2025 and into the first half of 2026. The analysis covers the Turkish Personal Data Protection Authority's expanding guidance framework, significant enforcement actions totaling TRY 352.5 million in fines, and critical regulatory shifts including new cybersecurity legislation and constitutional court decisions
TurkeyPrivacy
Gün + Partners
Gün + Partners
Article

New Pricing Communiqué Following The New Pricing Decision For Medicinal Products For Human Use: Increase Of The Euro Conversion Rate To 65% Of The Previous Year’s Average And Details Of The Pricing Incentive For The First Equivalent/Generic Product

Turkey's pharmaceutical pricing system undergoes a major restructuring with the publication of the New Pricing Communiqué on August 29, 2026, implementing significant changes including increased Euro/TRY conversion rates, incentive mechanisms for first generic market entry, and the introduction of value-based pricing concepts. The new regulations establish detailed provisions for special product categories while leaving certain implementation details to future secondary legislation.
TurkeyFood, Drugs, Healthcare, Life Sciences
Gün + Partners
Gün + Partners